Regeneron Pharmaceuticals Inc - Company & Market Research Reports

Home /
Companies /
Regeneron Pharmaceuticals Inc

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 79
Optical 75
Immune Disorders Drugs 73
Optical Disorders Drugs 66
Drug Discovery 43
Cardiovascular Drugs 42
Dermatological Drugs 37
Musculoskeletal Disorders Drugs 37
Biopharmaceuticals 36
Biotechnology 33
Genomics 27
Clinical Trials 21
Skin Cancer Drugs 19
Endocrine and Metabolic Disorders Drugs 19
Central Nervous System Drugs 18
Pharmaceuticals 18
Allergy and Immunology 17
Infectious Diseases Drugs 16
Respiratory Drugs 15
Drugs by Therapeutic Area 14
Infusions and Injectables 14
Allergy Drugs 13
Lung Cancer Drugs 12
Dermatology 10
Gastrointestinal Drugs 10
Oncology 10
Hematological Drugs 9
Leukemia Drugs 8
Needles and Syringes 8
Diagnostics 7
Prostate Cancer Drugs 6
Enzymes 6
Vaccines 6
Biosimilars and Biosuperiors 6
Asthma Drugs 6
Pharmaceutical Manufacturing 6
Drug Delivery 5
Gastroenterology 5
Company Reports 4
Therapeutic Area 4
Pulmonary Medicine 4
Lymphoma Drugs 4
Ovarian Cancer Drugs 4
Proteomics 4
Transdermal and Transmucosal Drug Delivery 4
Liver and Kidney Disorders Drugs 4
Pharmaceutical Intermediates 3
Diabetes Drugs 3
Colon Cancer Drugs 3
Cardiovascular Devices 3
Medical Devices 3
Pediatrics 3
Endocrinology 3
Sexual and Reproductive Health Drugs 3
Immunosuppressive Drugs 3
Liver Cancer Drugs 2
Healthcare Services 2
Cervical Cancer Drugs 2
Brain Cancer Drugs 2
Analgesics 2
Mental Disorders Drugs 2
Kidney Cancer Drugs 2
Laboratory Equipment 2
Cardiology 2
Neurology 1
Generic Drugs 1
Pharmacoeconomics 1
Fertility Services 1
Bladder Cancer Drugs 1
In Vitro Diagnostics 1
Infectious Disease Testing 1
Cholesterol Testing 1
Laboratory Testing 1
Cough and Cold Drugs 1
Inhalers and Nebulisers 1
Stem Cells 1
Blood Banking 1
Anesthetic Drugs 1
Biomarkers 1
Hematology 1
Nursing 1
Surgical Devices 1
Over the Counter (OTC) Drugs 1
Endoscopy 1
Pancreatic Cancer Drugs 1
Thyroid Cancer Drugs 1
Uterine Cancer Drugs 1
Nanomedicine 1
Anti-Obesity Drugs 1
Alzheimer's Disease Drugs 1
Psoriasis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

662 Results (Page 31 of 34)
- Relevance
  Sort by

Head and Neck Cancer Diagnostics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€3959EUR$4,490USD£3,452GBP

Chronic Rhinosinusitis - Pipeline Insight, 2025

 Clinical Trials
April 2025
40 Pages
Global

From

€882EUR$1,000USD£769GBP

€1102EUR$1,250USD£961GBP

Melanoma - Pipeline Review, H2 2020

 Drug Pipelines
November 2020
3809 Pages
Global

From

€2204EUR$2,500USD£1,922GBP

Immune Checkpoint Inhibitors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

 Report
January 2024
206 Pages
Global

€4404EUR$4,995USD£3,840GBP

Age Related Macular Degeneration (AMD) Market Size, Share & Industry Trends Analysis Report By Drug Type (Aflibercept, Ranibizumab and Others), By Disease Type (Wet and Dry), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030

 Report
July 2023
242 Pages
Global

From

€3174EUR$3,600USD£2,768GBP

NEED HELP FINDING THE RIGHT PRODUCT? Olha will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Healthcare Services Market Report 2025

 Report
April 2025
500 Pages
Global

From

€3959EUR$4,490USD£3,452GBP

LDL-C Lowering Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

 Report
February 2024
107 Pages
Global

From

€3500EUR$4,253USD£3,159GBP

Oropharyngeal Cancer - Pipeline Insight, 2025

 Clinical Trials
April 2025
50 Pages
Global

From

€1058EUR$1,200USD£923GBP

€1322EUR$1,500USD£1,153GBP

Intravitreal Injectables Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

 Report
August 2022
118 Pages
Global

From

€3967EUR$4,500USD£3,460GBP

Cardiovascular Risk Reduction Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, and Product Type

 Report
January 2024
106 Pages
Global

From

€3500EUR$4,253USD£3,159GBP

Atopic Dermatitis Market Insight, Epidemiology and Market Forecast -2032

 Report
February 2022
269 Pages
Global

From

€6701EUR$7,600USD£5,843GBP

€8376EUR$9,500USD£7,304GBP

Pediatric Medicines: Global Markets

 Report
November 2019
169 Pages
Global

From

€2425EUR$2,750USD£2,114GBP

SARS-CoV-2 Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

 Report
February 2024
78 Pages
Global

From

€3500EUR$4,253USD£3,159GBP

Immunology Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

 Report
February 2024
100 Pages
Global

From

€3500EUR$4,253USD£3,159GBP

US Alopecia Areata - Market Insight, Epidemiology And Market Forecast - 2032

 Report
November 2023
115 Pages
United States

From

€2645EUR$3,000USD£2,307GBP

€3306EUR$3,750USD£2,883GBP

Active Pharmaceutical Ingredient (API) Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€4363EUR$4,949USD£3,805GBP

Transforming Growth Factor (TGF) Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€882EUR$1,000USD£769GBP

€1102EUR$1,250USD£961GBP

Coronavirus (COVID-19) Current Therapy Global Market Report 2023

 Report
February 2023
250 Pages
Global

From

€4408EUR$5,000USD£3,844GBP

Lipodystrophy - Market Insight, Epidemiology And Market Forecast - 2032

 Report
February 2023
107 Pages
Global

From

€5290EUR$6,000USD£4,613GBP

€6612EUR$7,500USD£5,766GBP

Spinal Muscular Atrophy Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
January 2024
88 Pages
Global

From

€3500EUR$4,253USD£3,159GBP

662 Results (Page 31 of 34)
- 1
- 29
- 30
- 31
- 32
- 33

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.